Interestingly, for the group of diagnosis age below 60 or infiltrating ductal carcinoma, we found that a correlation between an improved survival with MALAT1 low expression was statistically significant and MALAT1 was an independent prognostic factor among them. The gene discussed is MALAT1; the disease is invasive ductal breast carcinoma.